Cagrilintide: all 47 studies that test it

Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaRecruitingNCT07817251Phase 3
• A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body WeightRecruitingNCT07745504Phase 3
• Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse EventsRecruitingNCT07607587Phase 1
• A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or ObesityRecruitingNCT07597018Phase 1
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightRecruitingNCT07564414Phase 3
• A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or ObesityRecruitingNCT07557953Phase 1
• Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)RecruitingNCT07527195Phase 1
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesRecruitingNCT07282613Phase 3
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightRecruitingNCT07253285Phase 3
• The Role of the Amylin Analogue Cagrilintide in Bone MetabolismRecruitingNCT07010432Phase 1
• Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 DiabetesCompletedNCT04982575Phase 2Results posted
• Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.CompletedNCT03856047Phase 2Results posted
• A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body WeightCompletedNCT07605052Phase 1
• A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body WeightWithdrawnNCT07357766Phase 3
• A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 DiabetesWithdrawnNCT07357740Phase 2
• Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With CagrilintideActive, not recruitingNCT07220759Phase 3
• Weight Loss in People Living With Overweight or Obesity Following Treatment With CagrilintideActive, not recruitingNCT07220642Phase 3
• A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termActive, not recruitingNCT07011667Phase 3
• A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyCompletedNCT06797869Phase 2
• A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With ObesityActive, not recruitingNCT06780449Phase 3
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or ObesityCompletedNCT06716307Phase 1
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothCompletedNCT06534411Phase 3
• Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseaseCompletedNCT06409130Phase 2
• Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 DiabetesCompletedNCT06403761Phase 1
• A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightCompletedNCT06388187Phase 3
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExerciseCompletedNCT06323174Phase 3
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without MetforminCompletedNCT06323161Phase 3
• A Study of How CagriSema Works on Appetite in People With Excess Body WeightCompletedNCT06267092Phase 1
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedNCT06221969Phase 3
• A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body WeightCompletedNCT06207877Phase 1
• A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightCompletedNCT06131437Phase 3
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboCompletedNCT06131372Phase 2
• A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorCompletedNCT06065540Phase 3
• A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose WeightCompletedNCT05996848Phase 3
• A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose WeightCompletedNCT05813925Phase 3
• A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy ParticipantsCompletedNCT05804162Phase 1
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsActive, not recruitingNCT05669755Phase 3
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightActive, not recruitingNCT05567796Phase 3
• A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the BodyCompletedNCT05564104Phase 1
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightCompletedNCT05394519Phase 3
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityCompletedNCT04940078Phase 1
• A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney FunctionCompletedNCT04209049Phase 1
• Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become PregnantCompletedNCT04074174Phase 1
• A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With ObesityCompletedNCT03787225Phase 1
• A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or ObeseCompletedNCT03600480Phase 1
• Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or OverweightCompletedNCT02958085Phase 1
• Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male SubjectsCompletedNCT02300844Phase 1

← Cagrilintide overview